Related Experiment Video
Updated: Jun 14, 2026

10:24
Morris Water Maze Test: Optimization for Mouse Strain and Testing Environment
Published on: June 22, 2015
21.6K
Multi-omics delineate growth factor network underlying exercise effects in an Alzheimer's mouse model
Xin Li1, Chaozhong Liu2, Wenbo Li1
1Department of Medicine - Endocrinology, Diabetes, and Metabolism, Baylor College of Medicine, Houston, Texas 77030, USA.
Biorxiv : the Preprint Server for Biology
|May 15, 2024
Summary
Physical exercise combats cognitive decline by activating growth factor signaling pathways in the brain. This research highlights how exercise enhances memory and suggests new therapeutic targets for Alzheimer's disease (AD).
Area of Science:
- Neuroscience
- Genomics
- Molecular Biology
Background:
- Physical exercise is a key factor in preventing age-related cognitive decline and neurodegenerative diseases such as Alzheimer's disease (AD).
- Understanding the molecular mechanisms behind exercise's benefits is crucial for developing effective interventions.
Approach:
- Single-nucleus RNA sequencing (snRNA-seq) and ATAC sequencing (ATAC-seq) were performed on the hippocampus of APPNL-G-F mice, a model for AD.
- Mice underwent voluntary wheel-running exercise to investigate exercise's effects on gene expression and chromatin accessibility.
Key Points:
- Exercise counteracted amyloid-induced changes in the hippocampus by modulating cell type-specific transcriptional networks.
- These networks involved activation of epidermal growth factor receptor (EGFR) and insulin signaling pathways.
- EGFR and phosphoinositide 3-kinases (PI3K) inhibition blocked exercise's cognitive benefits, while heparin-binding EGF (HB-EGF) administration improved memory in sedentary mice.
Conclusions:
- Exercise promotes neurogenesis and oligodendrocyte maturation via specific signaling pathways.
- EGF-related growth factor signaling is a druggable target for enhancing exercise-induced memory benefits.
- This study provides insights into therapeutic strategies for mitigating cognitive decline in AD.

